Jim Hindman
Direttore/Membro del Consiglio presso Urovant Sciences, Inc.
Provenienza dei contatti di primo grado di Jim Hindman
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jim Hindman tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer | |
Gibson, Dunn & Crutcher LLP
Gibson, Dunn & Crutcher LLP Miscellaneous Commercial ServicesCommercial Services Gibson, Dunn & Crutcher LLP provides legal services. It offers services to labor, employment, entertainment and media law, toxic torts and other environmental services. The company was founded in 1890 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RITE AID CORPORATION | Drugstore Chains | Director/Board Member Chief Administrative Officer | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Medical Specialties | Director of Finance/CFO | |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Treasurer | |
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Medical Specialties | Director/Board Member | |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Brigham Young University | College/University | Undergraduate Degree | |
ACCURAY INCORPORATED | Medical Specialties | Director/Board Member | |
Loyola Marymount University | College/University | Director/Board Member | |
Pepperdine University | College/University | Masters Business Admin | |
ASTELLAS PHARMA INC. | Pharmaceuticals: Major | President | |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | President | |
University of the Witwatersrand | College/University | Undergraduate Degree | |
Hiroshima University | College/University | Doctorate Degree | |
Big Brothers Big Sisters of Orange County | Director/Board Member | ||
SIENTRA, INC. | Medical Specialties | Director/Board Member | |
Paul Hastings LLP
Paul Hastings LLP Miscellaneous Commercial ServicesCommercial Services Paul Hastings LLP engages in the provision of legal services. It specializes in the areas of finance, fintech and payments, mergers and acquisitions, private equity, real state, restructuring, tax advisory, employment law, government, intellectual property, international arbitration, entertainment and media, and technology, media, and telecommunications. The company was founded in 1951 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Human Resources Officer | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman | |
ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
Schwarz BioSciences GmbH | Corporate Officer/Principal | ||
USC Marshall School of Business | College/University | Undergraduate Degree | |
Allergan Foundation | President | ||
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Harvard Business School | College/University | Masters Business Admin | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Meltin MMI KK
Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MYOVANT SCIENCES LTD. | Biotechnology | Chairman Director/Board Member | |
ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Compliance Officer Director/Board Member | |
Aatru Medical LLC
Aatru Medical LLC Medical SpecialtiesHealth Technology Aatru Medical LLC provides wound and damaged skin treatment. The company was incorporated in 2017 and is headquartered in Cleveland, OH. | Medical Specialties | Director/Board Member | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Human Resources Officer | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chairman Director/Board Member Director/Board Member Director/Board Member General Counsel Chief Executive Officer Director/Board Member Human Resources Officer Chief Tech/Sci/R&D Officer | |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman | |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Qlarity Imaging LLC
Qlarity Imaging LLC Medical/Nursing ServicesHealth Services Qlarity Imaging LLC engages in providing radiologists services. Its initial product is the first FDA-cleared computer-aided diagnosis software for radiology. The company is headquartered in Chicago, IL. | Medical/Nursing Services | Chief Executive Officer | |
BicycleTx Ltd.
BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Pharmaceuticals: Major | Chairman | |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chairman | |
Interfonction Ltd.
Interfonction Ltd. Building ProductsProducer Manufacturing Part of Interfonction Ltd., Interfonction is a Canadian company that manufactures aluminum and glass interior doors. The company is based in Sherbrooke, Canada. The company was founded in 1990 by Pierre Legault. The CEO is Johanne Tousignant. Interfonction was acquired by Interfonction /Private Group/ on December 31, 2014. | Building Products | Founder | |
University of Southern California Gould School of Law | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 36 |
Regno Unito | 5 |
Giappone | 4 |
Francia | 3 |
Singapore | 2 |
Settori
Health Technology | 32 |
Consumer Services | 9 |
Commercial Services | 6 |
Retail Trade | 2 |
Health Services | 2 |
Posizioni
Director/Board Member | 88 |
Corporate Officer/Principal | 22 |
Independent Dir/Board Member | 21 |
President | 17 |
Chief Executive Officer | 17 |
Contatti più connessi
- Borsa valori
- Insiders
- Jim Hindman
- Connessioni Società